ERG and prostate carcinoma: Furthermore, the TMPRSS2–ERG fusion may have an important prognostic and predictive value, because of which differentially regulated mRNAs (most notably ERG) in repeated experiments suggest that targeted therapy in prostate cancer could be aided by this biomarker.